About the Authors
- Hasiya Yusuf
-
Roles Data curation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Department of Internal Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States of America
- Vinita Gupta
-
Roles Writing – original draft, Writing – review & editing
Affiliation Division of Hematology &Oncology, Department of Internal Medicine, Jacobi Medical Center, New York City Health and Hospital Corporation, Bronx, New York, United States of America
- Ikponmwosa Osaghae
-
Roles Methodology, Writing – review & editing
Affiliation Department of Epidemiology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, United States of America
- Abhishek Kumar
-
Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: research.ak@gmail.com
Affiliations Division of Hematology &Oncology, Department of Internal Medicine, Jacobi Medical Center, New York City Health and Hospital Corporation, Bronx, New York, United States of America, Division of Hematology & Oncology, Department of Internal Medicine, Albert Einstein College of Medicine, Bronx, NY, United States of America
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: Abhishek Kumar has stocks and stock options in Abbvie, AVEO, Cara Therapeutics, Celgene, Iovance Biotherapeutics, Eli Lilly, Viking Therapeutics, SPDR S and P Biotech ETF, Agenus, Amgen, BioTelemetry, Bristol-Myers Squibb, Bio-Path Holdings, Inc, ChemBio Diagnostic Systems, CRISPR therapeutics, CVS Health, Editas Medicine, Five Prime Therapeutics, Immunomedics, Livongo, Medtronic, Northwest Biotherapeutics, PTC Therapeutics, Regeneron, Teladoc, Trovagene, Vertex, Globus Medical, Acadia Pharmaceuticals, ADMA Biologics, BeyondSpring Pharmaceuticals, Cardiff Oncology, IDEXX Laboratories, AIkido Pharma, Albireo Pharma, Blueprint Medicines, Precision, Biosciences, Novavax, Poseida Therapeutics, Surgalign, AstraZeneca, Contrafect, CryoLife, Geron, Johnson & Johnson/Janssen, Kronos, Ontrak, Spectrum Pharmaceuticals, Uniqure, Renalytix AI PLC, Sierra Oncology, Vericel, Viatris, CUE Biopharma, DermTech, Gevo, Jazz Pharmaceuticals, Purple Biotech, Protagonist Therapeutics, Schrodinger, and Sensei Biotherapeutics. He also received travel and hotel funding for a lecture from the American Society of Clinical Oncology. All other authors have no competing interests.